Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News AstraZeneca and Pfizer to support new Cancer Research UK project

AstraZeneca and Pfizer to support new Cancer Research UK project

4th February 2011

AstraZeneca and Pfizer are to provide funding support for a new Cancer Research UK project designed to improve access to personalised medicines among NHS patients.

A total of 5.5 million pounds will be invested by the three organisations into the Stratified Medicine Programme, which aims to look at ways of introducing genetic tests to improve diagnosis across the UK.

This will involve the creation of a database of oncology data to support future research, as well as the development of a multi-gene panel that can test for biomarkers associated with a wide array of current and future treatments.

It will also establish a set of standards and guidelines for molecular diagnosis of tumours for use by NHS clinicians.

Dr Susan Galbraith, vice-president and head of oncology at AstraZeneca's innovative medicines division, said: "It is our view that better understanding of which patients will benefit from treatment with currently available and new therapies is the way forward in fighting this disease."

This comes after AstraZeneca agreed a separate deal with Cancer Research UK last month that will see them ally on conducting clinical trials for several innovative combination oncology treatments.ADNFCR-8000103-ID-800385653-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.